DRUG · Unmapped registry intervention
PD-0325901
Find medicine records ·
Find other trials using this name
Clinical trial
MEK Inhibitor PD-325901 To Treat Advanced Non-Small Cell Lung Cancer
NCT00174369
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedMEK Inhibitor PD-325901 To Treat Advanced Non-Small Cell Lung Cancer
Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Carcinoma, Non-Small-Cell Lungunresolved
Interventions
PD-0325901DRUG
Sponsors & collaborators
Pfizerlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00174369 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.